Literature DB >> 23519720

Is the risk and nature of CVD the same in type 1 and type 2 diabetes?

Lindsey Duca1, Rachel Sippl, Janet K Snell-Bergeon.   

Abstract

The incidence of both type 1 and type 2 diabetes is increasing globally, most likely explained by environmental changes, such as changing exposures to foods, viruses, and toxins, and by increasing obesity. While cardiovascular disease (CVD) mortality has been declining recently, this global epidemic of diabetes threatens to stall this trend. CVD is the leading cause of death in both type 1 and type 2 diabetes, with at least a two- to fourfold increased risk in patients with diabetes. In this review, the risk factors for CVD are discussed in the context of type 1 and type 2 diabetes. While traditional risk factors such as dyslipidemia, hypertension, and obesity are greater in type 2 patients than in type 1 diabetes, they explain only about half of the increased CVD risk. The role for diabetes-specific risk factors, including hyperglycemia and kidney complications, is discussed in the context of new study findings.

Entities:  

Mesh:

Year:  2013        PMID: 23519720      PMCID: PMC8986271          DOI: 10.1007/s11892-013-0380-1

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  97 in total

1.  Abnormal glucose regulation and gender-specific risk of fatal coronary artery disease in the HUNT 1 study.

Authors:  Erik Madssen; Lars Vatten; Tom Ivar Nilsen; Kristian Midthjell; Rune Wiseth; Ane Cecilie Dale
Journal:  Scand Cardiovasc J       Date:  2012-03-09       Impact factor: 1.589

2.  Marked temporal increase in the incidence of type 1 and type 2 diabetes among young adults in Finland.

Authors:  N Lammi; P A Blomstedt; E Moltchanova; J G Eriksson; J Tuomilehto; M Karvonen
Journal:  Diabetologia       Date:  2008-03-04       Impact factor: 10.122

3.  C-reactive protein concentration predicts mortality in type 2 diabetes: the Diabetes Heart Study.

Authors:  A J Cox; S Agarwal; D M Herrington; J J Carr; B I Freedman; D W Bowden
Journal:  Diabet Med       Date:  2012-06       Impact factor: 4.359

4.  Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes.

Authors:  R Paul Wadwa; Gregory L Kinney; Lorraine Ogden; Janet K Snell-Bergeon; David M Maahs; Elaine Cornell; Russell P Tracy; Marian Rewers
Journal:  Int J Biochem Cell Biol       Date:  2005-10-18       Impact factor: 5.085

5.  Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study.

Authors:  Janet K Snell-Bergeon; Nancy A West; Elizabeth J Mayer-Davis; Angela D Liese; Santica M Marcovina; Ralph B D'Agostino; Richard F Hamman; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2010-04-06       Impact factor: 5.958

6.  High prevalence of hirsutism and menstrual disorders in obese adolescent girls and adolescent girls with type 1 diabetes mellitus despite different hormonal profiles.

Authors:  Dinane Samara-Boustani; Ana Colmenares; Caroline Elie; Myriam Dabbas; Jacques Beltrand; Virgile Caron; Claude Ricour; Paul Jacquin; Nadia Tubiana-Rufi; Claire Levy-Marchal; Christine Delcroix; Delphine Martin; Lila Benadjaoud; Evelyne Jacqz Aigrain; Christine Trivin; Kathleen Laborde; Elisabeth Thibaud; Jean-Jacques Robert; Michel Polak
Journal:  Eur J Endocrinol       Date:  2011-11-29       Impact factor: 6.664

7.  Rates and determinants of coronary and abdominal aortic artery calcium progression in the Veterans Affairs Diabetes Trial (VADT).

Authors:  Aramesh Saremi; Thomas E Moritz; Robert J Anderson; Carlos Abraira; William C Duckworth; Peter D Reaven
Journal:  Diabetes Care       Date:  2010-08-31       Impact factor: 19.112

8.  Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes.

Authors:  S P Laing; A J Swerdlow; S D Slater; A C Burden; A Morris; N R Waugh; W Gatling; P J Bingley; C C Patterson
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

9.  Incidence of diabetes in youth in the United States.

Authors:  Dana Dabelea; Ronny A Bell; Ralph B D'Agostino; Giuseppina Imperatore; Judith M Johansen; Barbara Linder; Lenna L Liu; Beth Loots; Santica Marcovina; Elizabeth J Mayer-Davis; David J Pettitt; Beth Waitzfelder
Journal:  JAMA       Date:  2007-06-27       Impact factor: 56.272

10.  Increasing incidence of pediatric type 1 diabetes mellitus in Southeastern Wisconsin: relationship with body weight at diagnosis.

Authors:  Jennifer Evertsen; Ramin Alemzadeh; Xujing Wang
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more
  8 in total

Review 1.  Morbidity and mortality in young-onset type 2 diabetes in comparison to type 1 diabetes: where are we now?

Authors:  Jencia Wong; Maria Constantino; Dennis K Yue
Journal:  Curr Diab Rep       Date:  2015-01       Impact factor: 4.810

2.  Cross-Sectional Positive Association of Serum Lipids and Blood Pressure With Serum Sodium Within the Normal Reference Range of 135-145 mmol/L.

Authors:  Shouguo Gao; Xiangqin Cui; Xujing Wang; Maurice B Burg; Natalia I Dmitrieva
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-29       Impact factor: 8.311

3.  Self-management of physical activity in adults with type 1 diabetes.

Authors:  Margaret M McCarthy; Robin Whittemore; Georica Gholson; Margaret Grey
Journal:  Appl Nurs Res       Date:  2017-02-03       Impact factor: 2.257

4.  Isolated hyperglycaemia does not increase VLDL-triacylglycerol secretion in type 1 diabetic men.

Authors:  Rakel F Johansen; Esben Søndergaard; Lars Peter Sørensen; Birgitte Nellemann; Jens S Christiansen; Søren Nielsen
Journal:  Diabetologia       Date:  2014-11-11       Impact factor: 10.122

5.  Clinical and dietary predictors of common carotid artery intima media thickness in a population with type 1 and type 2 diabetes: A cross-sectional study.

Authors:  Kristina S Petersen; Jennifer B Keogh; Peter J Meikle; Manohar L Garg; Peter M Clifton
Journal:  World J Diabetes       Date:  2017-01-15

6.  Novel therapeutic effects of sesamin on diabetes-induced cardiac dysfunction.

Authors:  Tran Duong Thuy; Nam Nhut Phan; Chih-Yang Wang; Han-Gang Yu; Shu-Yin Wang; Pung-Ling Huang; Yi-Yin Do; Yen-Chang Lin
Journal:  Mol Med Rep       Date:  2017-03-30       Impact factor: 2.952

7.  Area deprivation and the prevalence of type 2 diabetes and obesity: analysis at the municipality level in Germany.

Authors:  Nina Grundmann; Andreas Mielck; Martin Siegel; Werner Maier
Journal:  BMC Public Health       Date:  2014-12-13       Impact factor: 3.295

8.  Ganglion cell layer thickening in well-controlled patients with type 1 diabetes: an early sign for diabetic retinopathy?

Authors:  Bianca S Gerendas; Katja Hatz; Alexandra Kaider; Henryk Zulewski; Roger Lehmann; Alessio Montuoro; Ursula Schmidt-Erfurth; Christian Pruente
Journal:  Acta Ophthalmol       Date:  2019-10-25       Impact factor: 3.761

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.